- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01529385
Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes
Efficacy of a Mild Compression Diabetic Sock Versus A Non- Compression Diabetic Sock in the Control of Lower Extremity Edema in Patients With Diabetes: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Peripheral arterial disease (PAD) is commonly associated with diabetes. Clinicians are often reluctant to apply compressive stockings to patients with diabetes and swollen legs due to fear of exacerbating the symptoms of PAD. The study sock is a newly formulated sock that offers mild compression (18-25mmHg). The sock is made especially for the diabetic patient who suffers from concomitant lower extremity edema.
Eighty patients with diabetes and lower extremity edema will be recruited. Upon ensuring enrollment criteria are met, baseline edema (as measured by circumference of foot, ankle and calf), ankle brachial index (ABI), skin perfusion pressure, and cutaneous fluid level (as measured by MoistureMeter) will be assessed. Subjects will then be provided four pairs of socks. Subjects will be randomized in a 1:1 distribution to receive either the mild compression diabetic socks or a standard diabetic sock. They will return for four weekly follow up visits.
Additionally a sub-set of 30 subjects will be monitored for changes in physical activity pre and post sock usage. Physical activity monitors will be used to assess daily physical activity for 48hrs prior to receiving the socks and after wearing the socks for four weeks an additional 48hrs will be monitored.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
North Chicago, Illinois, United States, 60064
- Rosalind Franklin University Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female with lower extremity edema aged 18 or older with the ability and willingness to provide Informed consent
- Patient's ankle-brachial systolic pressure index > 0.6 and toe-brachial index > 0.3
- Patient is willing to participate in all procedures and follow up evaluations necessary to complete the study.
- Patient has diabetes type 1 or type 2 confirmed by patient's primary care physician.
Exclusion Criteria:
- Patients with active wound infection, or untreated osteomyelitis, gangrene
- Patients with dementia, or impaired cognitive function that would prohibit study compliance
- Patients with wide spread malignancy or systemically immuno-compromising disease
- Patients who are unable or unwilling to participate in all procedures and follow up evaluations
- Patient with deep and/or large ulcers that require copious bandaging and may affect efficacy of socks. Patients with superficial ulcers that only require a light dressing are not excluded. The ulcer, if present, must be superficial and cannot exhibit any clinical signs of infection
- Patients with restless leg syndrome, Parkinson's disease, or other disease that will cause involuntary movement during microvascular assessment
- Patients with severe edema or calf circumference greater than 24" or 46cm
- Patients with severe lymphedema
- Patients with edema that in the opinion of the investigator requires higher compression than the 18-25mmHg provided by the compression socks
- Patients who are currently wearing compression hose. (Patients who have been prescribed compression hose but have not worn compression stockings for the past 6 months can be included in the study)
- Patients unable to walk one hundred feet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mild Compression Diabetic Sock
Diabetic socks that provide 18-25mm Hg of pressure to the lower extremities.
|
A diabetic sock that provides mild compression (18-25mm Hg) is to be worn everyday for four weeks
|
Other: Standard Diabetic Sock
A standard diabetic sock that is designed to limit foot ulcer formation, but does not provide compression to the leg.
|
A diabetic sock that is not designed to provide compression is to be worn everyday for four weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cutaneous Water Content
Time Frame: change from baseline after 4 weeks of sock usage
|
Cutaneous water content was measured non-invasively by tissue dielectric constant (MoistureMeter) at a single location: 2 inches distal and 2 inches lateral to the fibular head.
|
change from baseline after 4 weeks of sock usage
|
Calf Edema
Time Frame: change from baseline after 4 weeks of sock usage
|
The circumference of calf was measured by a tape measure.
|
change from baseline after 4 weeks of sock usage
|
Ankle Edema
Time Frame: change from baseline after 4 weeks of sock usage
|
The circumference of ankle was measured by a tape measure.
|
change from baseline after 4 weeks of sock usage
|
Toe Brachial Index
Time Frame: change from baseline after 4 weeks of sock usage
|
ratio of systolic blood pressure of toe relative to systolic blood pressure of arm
|
change from baseline after 4 weeks of sock usage
|
Ankle Brachial Index
Time Frame: change from baseline after 4 weeks of sock usage
|
ratio of systolic blood pressure of ankle relative to systolic blood pressure of arm
|
change from baseline after 4 weeks of sock usage
|
Foot Edema
Time Frame: change from baseline after 4 weeks of sock usage
|
The circumference of the foot was measured by a tape measure.
|
change from baseline after 4 weeks of sock usage
|
Microcirculation for Medial Calf
Time Frame: change from baseline after 4 weeks of sock usage
|
microcirculation as measured by skin perfusion pressure
|
change from baseline after 4 weeks of sock usage
|
Microcirculation for Lateral Calf
Time Frame: change from baseline after 4 weeks of sock usage
|
microcirculation as measured by skin perfusion pressure
|
change from baseline after 4 weeks of sock usage
|
Microcirculation for Dorsum of Foot
Time Frame: change from baseline after 4 weeks of sock usage
|
microcirculation as measured by skin perfusion pressure
|
change from baseline after 4 weeks of sock usage
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity Level
Time Frame: baseline and after four weeks of wearing the socks
|
Physical activity monitors will be used to assess physical activity patters of participants for 48 hours prior to initiating sock usage and for 48 hours after the participants have worn the socks for four weeks.
|
baseline and after four weeks of wearing the socks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Stephanie Wu, DPM, MS, Rosalind Franklin University of Medicine and Science
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ORT 112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
National Cardiovascular Center Harapan Kita Hospital...CompletedMyocardial Edema
-
OcugenNot yet recruitingDiabetic Macular Edema | Center Involved Diabetic Macular Edema
-
Ellianne M. NasserRecruitingBone Marrow EdemaUnited States
-
OculisICON plcRecruitingDiabetic Macular EdemaUnited States
-
Novartis PharmaceuticalsNot yet recruiting
Clinical Trials on mild compression diabetic sock
-
Istituto Ortopedico RizzoliCompleted
-
National University Hospital, SingaporeCompletedDeep Vein Thrombosis | Ankle Joint ContractureSingapore
-
University of California, San DiegoCompletedHealthy | DiabetesUnited States
-
Columbia UniversityCompletedCIPN - Chemotherapy-Induced Peripheral NeuropathyUnited States
-
University of Alabama at BirminghamNational Eye Institute (NEI)Recruiting